Nomura Asset Management Co. Ltd. Increases Stake in Kenvue Inc. $KVUE

Nomura Asset Management Co. Ltd. boosted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 21.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,491,548 shares of the company’s stock after acquiring an additional 618,720 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Kenvue were worth $60,229,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of KVUE. Norges Bank purchased a new position in Kenvue during the fourth quarter valued at approximately $756,862,000. Van ECK Associates Corp grew its holdings in Kenvue by 101.3% in the third quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after purchasing an additional 9,240,434 shares during the period. American Century Companies Inc. grew its holdings in Kenvue by 22.4% in the third quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock valued at $601,267,000 after purchasing an additional 6,781,640 shares during the period. Bessemer Group Inc. grew its holdings in Kenvue by 156.2% in the fourth quarter. Bessemer Group Inc. now owns 8,491,343 shares of the company’s stock valued at $146,475,000 after purchasing an additional 5,177,404 shares during the period. Finally, Mondrian Investment Partners LTD acquired a new stake in Kenvue in the third quarter valued at approximately $79,269,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 1.59% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have commented on KVUE. UBS Group dropped their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Barclays dropped their price objective on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. Canaccord Genuity Group raised their price objective on Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Citigroup dropped their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $19.33.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $17.29 on Monday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The business’s 50 day moving average price is $17.40 and its 200-day moving average price is $17.46. The firm has a market capitalization of $33.19 billion, a PE ratio of 20.34, a P/E/G ratio of 1.31 and a beta of 0.54. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $23.90.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.24 earnings per share. As a group, equities research analysts expect that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, May 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. Kenvue’s payout ratio is currently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.